VXA-CoV2-1.1-S

Drug identity checked against registry records

Also recorded as Oral Tableted Ad5 COVID-19 Vaccine

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Ph 2 Trial With an Oral Tableted COVID-19 VaccineNCT05067933VaxartPhase 2Terminated2022-06-10Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.